Literature DB >> 31545362

The prevalence of osteoporosis tested by quantitative computed tomography in patients with different glucose tolerances.

Zihou Zhao1, Liangying Wang2, Zuodi Fu2, Linong Ji3, Yufeng Li2, Xiaohong Wu4.   

Abstract

AIM: The objectives of the present study were to compare bone characteristics with QCT and other metabolic factors relevant to bone health in subjects with normal glucose tolerance, impaired glucose tolerance and diabetes and to evaluate the association of various lab factors with bone characteristics qualified by QCT.
METHODS: This cross-sectional population-based survey of diabetes and metabolic syndrome was conducted in Pinggu, China. The oral glucose tolerance test (OGTT) was conducted, and QCT was tested. The volumetric bone mineral density (vBMD) of Lumbar vertebra 2-4 was measured.
RESULTS: Among the 4001 eligible participants, the average age was 47.41±11.86 years. The prevalence of osteoporosis evaluated by QCT was 10.6% in the NGT group, 14.8% in the IGT group, and 16.9% in the DM group. Multivariate linear regression analysis showed that age was negatively associated with vBMD, while BMI and the waist-hip ratio were positively associated with vBMD across all participants. However, the levels of HbA1c, FPG and PPG were not associated with vBMD after adjusting for sex, age, systolic and diastolic blood pressure, BMI, total cholesterol, triglyceride, LDL-c, HDL-c, FT4, FT3, TSH, UACR, CRE, and SUA.
CONCLUSION: We found that the prevalence of osteoporosis evaluated by QCT was 10.6% in the NGT group, 14.8% in the IGT group, and 16.9% in the DM group. The levels of HbA1c, FPG and PPG were not associated with vBMD after adjusting for metabolic factors in a Chinese sample. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2019        PMID: 31545362     DOI: 10.1210/clinem/dgz036

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Increased Glycemic Variability Evaluated by Continuous Glucose Monitoring is Associated with Osteoporosis in Type 2 Diabetic Patients.

Authors:  Rong Huang; Huiying Wang; Ziyang Shen; Tingting Cai; Yunting Zhou; Yuming Wang; Wenqing Xia; Bo Ding; Rengna Yan; Huiqin Li; Jindan Wu; Jianhua Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-06       Impact factor: 6.055

2.  Association Between Indices of Body Composition and Metabolically Unhealthy Phenotype in China: A Cross-Sectional Study.

Authors:  Fang Lv; Xiaoling Cai; Yufeng Li; Zuodi Fu; Xiuying Zhang; Xianghai Zhou; Xueyao Han; Linong Ji
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-09       Impact factor: 6.055

3.  Long-Term Effects in Bone Mineral Density after Different Bariatric Procedures in Patients with Type 2 Diabetes: Outcomes of a Randomized Clinical Trial.

Authors:  Fernando Guerrero-Pérez; Anna Casajoana; Carmen Gómez-Vaquero; Nuria Virgili; Rafael López-Urdiales; Laura Hernández-Montoliu; Jordi Pujol-Gebelli; Javier Osorio; Anna Prats; Anna Vidal-Alabró; Manuel Pérez-Maraver; Sonia Fernández-Veledo; Joan Vendrell; Nuria Vilarrasa
Journal:  J Clin Med       Date:  2020-06-11       Impact factor: 4.241

4.  Association of circulating B-type natriuretic peptide with osteoporosis in a Chinese type 2 diabetic population.

Authors:  Pan Chen; Pijun Yan; Qin Wan; Zhihong Zhang; Yong Xu; Ying Miao; Jun Yang
Journal:  BMC Musculoskelet Disord       Date:  2021-03-10       Impact factor: 2.362

5.  Hyperglycemia Is Not Associated With Higher Volumetric BMD in a Chinese Health Check-up Cohort.

Authors:  Ling Wang; Kaiping Zhao; Xiaojuan Zha; Limei Ran; Heng Su; Yingying Yang; Qing Shuang; Yandong Liu; Li Xu; Glen M Blake; Xiaoguang Cheng; Klaus Engelke; Annegreet Vlug
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-03       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.